| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), PCSA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 67.5K | - | - | |
| Dir | 38.7K | - | - | |
| Dir | 38.7K | - | - | |
| Dir | 38.7K | - | - | |
| Other | 21.7K | $41.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Ng George K | Chief Executive Officer | Buy | 3,057 | $1.93 | $5,900.01 | +24.6% | |
| Jun 30, 2026 | Skibsted Russell | Chief Financial Officer | Buy | 3,277 | $1.93 | $6,324.61 | +24.4% | |
| Jun 30, 2026 | Young David | Pres. Research &Development | Buy | 2,531 | $1.93 | $4,884.83 | +13.2% | |
| Jun 30, 2026 | Lin Patrick | Chief Business - Strategy Off | Buy | 2,106 | $1.93 | $4,064.58 | +19.1% | |
| Jun 30, 2026 | Guy Wendy | Chief Administrative Officer | Buy | 2,436 | $1.93 | $4,701.48 | +20.4% | |
| Jun 15, 2026 | Skibsted Russell | Chief Financial Officer | Buy | 2,654 | $2.22 | $5,891.88 | +24.7% | |
| Jun 15, 2026 | Young David | Pres. Research &Development | Buy | 2,067 | $2.22 | $4,588.74 | +12.1% | |
| Jun 15, 2026 | Ng George K | Chief Executive Officer | Buy | 2,465 | $2.22 | $5,472.30 | +24.7% | |
| Jun 15, 2026 | Lin Patrick | Chief Business - Strategy Off | Buy | 1,831 | $2.22 | $4,064.82 | +20.0% | |
| Jun 15, 2026 | Guy Wendy | Chief Administrative Officer | Buy | 2,118 | $2.22 | $4,701.96 | +21.5% |